Focus

Longevity Investors: Angels and VC Firms

The RaiseHunt database lists 124 Longevity investors: 24 angel investors and 100 people at 48 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, New York and Boston.

Strongest in San Francisco, New York and Boston

Common stages: Seed and Series A

124
Longevity investors
24
Angel investors
100
People at VC/PE firms
48
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

124 Longevity investors

Showing 1-20

Filters
Peter H. Diamandis
Peter H. Diamandis

Co-Founder

Santa Monica, United States
AngelOperator angel
FinTechHealthcare
View profile
Marc P. Bernegger
Marc P. Bernegger

Founding Partner

Zürich, Switzerland
AngelOperator angel
ConsumerFinTech
View profile
Tobias Reichmuth
Tobias Reichmuth

Hon. Chairman & Founder

Zug, Switzerland
AngelOperator angel
Healthcare
View profile
Bill Cherman
Bill Cherman

angel investor and operator angel

San Francisco, United States
AngelOperator angel
ConsumerHealthcare
View profile
Christopher Tracy
Christopher Tracy

Investor

Orlando, United States
Venture capital
AIClimate
View profile
Facundo Garretón
Facundo Garretón

Founder & C.E.O

Uruguay
AngelOperator angel
ConsumerFood
View profile
Marianne Mertens
Marianne Mertens

Investment Committee Member

Munich, Germany
Venture capital
Healthcare
View profile
Simona Testoni
Simona Testoni

impact

Milan, Italy
Venture capital
Healthcare
View profile
Imran Shaikh
Imran Shaikh

Affiliated

Muscat, Oman
Corporate VC
AIHealthcare
View profile
Noramay Cadena
Noramay Cadena

Cofounder & Managing Partner

Los Angeles, United States
AcceleratorFamily Office
AIClimate
View profile
Nichol Bradford
Nichol Bradford

Co-Founder

San Francisco, United States
Corporate VCVenture capital
AIEducation
View profile
Olga Laouchez
Olga Laouchez

EIR

New York, United States
AcceleratorVenture capital
AIClimate
View profile
Stefano Vitella Ciia
Stefano Vitella Ciia

impact

Italy
Venture capital
Healthcare
View profile
Shefali Sanghi
Shefali Sanghi

Strategy Consultant

New York, United States
Venture capital
AIClimate
View profile
Jodi Morris
Jodi Morris

Investor & Advisor

Santa Fe, United States
Venture capital
AIClimate
View profile
Katrina Sather
Katrina Sather

Investor

Seattle, United States
Syndicate / Angel groupVenture capital
AIClimate
View profile
Jana Mike
Jana Mike

Mentee

San Francisco, United States
AcceleratorSyndicate / Angel group
AICommerce
View profile
Christophe Spoerry
Christophe Spoerry

angel investor and operator angel

Cannes, France
AngelOperator angel
FinTechSaaS
View profile
Jennifer Ehlen-Albrecht
Jennifer Ehlen-Albrecht

Managing Partner

St Louis, United States
Venture capital
AICommerce
View profile
Tim Juergens
Tim Juergens

SeedLink SL

Spain
Venture capital
Healthcare
View profile

84 of 124 Longevity investors, A to Z

Grouped by first letter. Name and profile link only, the detailed rows are in the table above.
Show

A11

  • Adam Stuart
  • Aki Ohashi
  • Alexander Pickett
  • Alexandra Sharon Bause
  • Alix Marduel
  • Altar Munis
  • Amalia Formoso
  • Amritha Appaswami
  • Anastasia Bottos
  • Artem A. Trotsyuk
  • Aya Suzuki

B5

  • Ben Hassler
  • Ben Tomaszewski
  • Beth Cohen
  • Blerina Sanocki
  • Bodil Arlander

C1

  • Christina Jenkins

D5

  • Dan Herr
  • Daniel Ek
  • David Berry
  • David Berry
  • Dmitry Kaminskiy

E4

  • Elizabeth H.
  • Elizabeth Torres
  • Emilian Popa
  • Emily Rhen

F2

  • Fatimah Bello
  • Franco Cortese

G2

  • Gabriel Kienberger
  • Guenther Dobrauz-Saldapenna

H3

  • Hannah Bronfman
  • Hannah Konitshek
  • Hayk Danielyan

J10

  • Jacob Peters
  • James Fickel
  • Jan Adams
  • Jan Adams
  • Janet Gurwitch
  • Jean-Evrard Dominicé
  • Joanna Zhu
  • John Reynertson
  • Judy Curry
  • Julio de Unamuno IV

K2

  • Karly Kaplan
  • Katerina Stroponiati

L5

  • Lawrence Maina
  • Liam Cole
  • Lisa Dyson
  • Lyne Landry
  • Lynn Marsh

M3

  • Madison Flood
  • Matthew Miller
  • Milena Bursztyn

O3

  • Ole Mensching
  • Oleg Teterin
  • Omiros D. Sarikas

P5

  • Paolo Binetti
  • Patrick Nicoll
  • Petr Novotný
  • Petr Sramek
  • Pradeep Killamsetty

R2

  • Rakesh Somani
  • Robin Farmanfarmaian

S10

  • Saima Hasan
  • Salil S. Jha
  • Sally Cole
  • Sean Mahsoul
  • Sebastian Döring
  • Sébastien Lacroix
  • Sergei Glukhov
  • Sergej Fedorovič
  • Sergey Young
  • Sourav Sinha

T3

  • Ted Moskovitz
  • Tim Davis
  • Tony Robbins

U1

  • Ulrich K.

V5

  • Valentina Vitols Bello
  • Varun Verma
  • Veeral Mehta
  • Veronica Gominho
  • Vlad Cernouţan

W1

  • Whit Hill

Y1

  • Yvette Sadler Butler

Frequently asked questions

How many Longevity investors are on RaiseHunt?

RaiseHunt currently lists 124 Longevity investors.

Are Longevity investors angels or funds?

Both. 24 are angel investors putting in their own money, and 100 are people making investment decisions at 48 firms.

Where are most Longevity investors based?

The largest concentrations are in San Francisco, New York and Boston.

What stage do Longevity investors invest at?

Most list Seed and Series A among the rounds they take part in.

How do I contact Longevity investors?

Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.

Is the list of Longevity investors free to browse?

Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.

Do Longevity investors only back Longevity companies?

No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.

What do investors look at first?

The team and the problem, in that order, before the product. Early on there is rarely enough traction to argue from numbers alone, so the question they are answering is whether these particular people are likely to work this problem out.

Should I raise from one investor or several?

Several, in almost every case. A single backer concentrates the risk of the round collapsing if that one conversation goes cold, and a group brings more introductions later. Rounds are usually assembled from a lead plus others who follow.

How do I follow up without being annoying?

Follow up with new information rather than a reminder. A short note saying what changed since you last wrote gives the reader a reason to reply, where "just checking in" gives them none. Two or three of those, spaced out, is normal and expected.

What if no Longevity investor replies?

Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.

What is the difference between an angel investor and a VC fund?

An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.

Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal